631 Lake Avenue | Asbury Park, NJ 07712
GET IN TOUCH: 732-414-6670
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Make a difference that lasts a lifetime!
Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.
Meet just a few of our boys living with this fatal disease.
13 cents a day can save a child.
Join our team as we raise money to #savethefirstchild.
Meet just a few of our boys living with this fatal disease.
13 cents a day can save a child.
Join our team as we raise money to #savethefirstchild.
Indulge in an evening of exceptional wines, networking, and fun, all while supporting JAR of Hope, an organization dedicated to raising awareness and funds for Duchenne Muscular Dystrophy research.
Duchenne muscular dystrophy (DMD) is one of the rarest diseases on Earth. DMD is a fatal, muscle-wasting disease you are born with. It occurs once in every 3,500 live births and effects mostly boys. In the United States, with a population of over 330,000,000 people, only about 20,000 children are stricken with Duchenne. And there is no cure.
Our goal is to find a cure for Duchenne muscular dystrophy. With organized fundraising events and support from you, we can continue our mission and turn the dream of finding a cure into a reality.
We have partnered with the University of Florida College of Medicine and RESTEM LLC to to initiate an important trial for Duchenne muscular dystrophy (DMD).
Authorization has been granted to begin Phase 1 of the trial. Here, a "randomized, double-blind, placebo-controlled Cross Over study to assess the safety, tolerability, and preliminary efficacy of Umbilical Cord Lining stem cells (ULSC) in Pediatric patients with Duchenne muscular dystrophy (DMD).”
732-414-6670
james@jarofhope.org
631 Lake Avenue
Asbury Park NJ 07712
JAR of Hope is a 501(c)(3) registered nonprofit organization.
Federal EIN 46-4134019